ActivBiotics

ActivBiotics is a biopharmaceutical company focused on developing innovative microbial therapeutics aimed at enhancing human health through targeted treatments. ActivBiotics, founded in 1996 and headquartered in Lexington, US, specializes in microbial therapeutics. The company was acquired by TrioBiotics Pharma AG in July 2010 for EUR 2 million. The acquisition represents a pivotal moment in the company's strategic direction, enhancing its capabilities in drug development and expanding its market reach.

The founder's details are not publicly available, and no subsidiaries or parent companies are mentioned. ActivBiotics develops innovative microbial therapeutics designed to improve human health. The company's offerings are aimed at addressing specific health challenges through targeted treatments, catering primarily to healthcare providers and patients in various regions. ActivBiotics generates revenue through sales of its innovative therapeutics, with financial details not publicly disclosed.

The company operates on a structured model that includes both direct sales and potential subscription agreements for healthcare providers. ActivBiotics plans to leverage its recent acquisition by TrioBiotics Pharma AG to enhance its product development capabilities and expand into new markets. The company is focusing on introducing new microbial therapeutics by 2023 and aims to enter the European and Asian markets to broaden its reach. The recent funding will support product development and market entry strategies.